Tosi, Flavia

Metformin Effects on Clinical Features, Endocrine and Metabolic Profiles, and Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled 6-Month Trial, followed by Open, Long-Term Clinical Evaluation1

Moghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., Zanolin, E., & Muggeo, M. (2000) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 660

Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome

Moghetti, P., Tosi, F., Bonin, C., Di Sarra, D., Fiers, T., Kaufman, J.-M., Giagulli, V. A., Signori, C., Zambotti, F., Dall'Alda, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 262

Insulin resistance and PCOS: chicken or egg?

Moghetti, P., & Tosi, F. (2021) · Journal of Endocrinological Investigation

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 209

Insulin resistance in a large cohort of women with polycystic ovary syndrome: A comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes

Tosi, F., Bonora, E., & Moghetti, P. (2017) · Human Reproduction

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 163

Metformin Effects on Clinical Features, Endocrine and Metabolic Profiles, and Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled 6-Month Trial, Followed by Open, Long-Term Clinical Evaluation

Moghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., Zanolin, E., & Muggeo, M. (2000) · Obstetrical & Gynecological Survey

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 158

Flutamide in the treatment of hirsutism: Long-term clinical effects, endocrine changes, and androgen receptor behavior

Moghetti, P., Castello, R., Negri, C., Tosi, F., Magnani, C. M., Fontanarosa, M. C., Armanini, D., & Muggeo, M. (1995) · Fertility and Sterility

Ovarian function and disordersAdrenal Hormones and Disorders

Cited by 81

Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome

Tosi, F., Di Sarra, D., Kaufman, J.-M., Bonin, C., Moretta, R., Bonora, E., Zanolin, E., & Moghetti, P. (2015) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

Implications of Androgen Assay Accuracy in the Phenotyping of Women With Polycystic Ovary Syndrome

Tosi, F., Fiers, T., Kaufman, J.-M., Dall'Alda, M., Moretta, R., Giagulli, V. A., Bonora, E., & Moghetti, P. (2016) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersClinical Laboratory Practices and Quality Control

Cited by 67

Serum testosterone predicts cardiorespiratory fitness impairment in normal‐weight women with polycystic ovary syndrome

Bacchi, E., Negri, C., Di Sarra, D., Tosi, F., Tarperi, C., Moretta, R., Schena, F., Bonora, E., Kaufman, J., & Moghetti, P. (2015) · Clinical Endocrinology

Ovarian function and disordersCardiovascular and exercise physiology

Cited by 10

Plasma concentrations of glucagon during hyperglycemic clamp with or without somatostatin infusion in obese subjects

Bonora, E., Moghetti, P., Cacciatori, V., Zenere, M., Tosi, F., Travia, D., Zoppini, G., Perobelli, L., & Muggeo, M. (1990) · Acta Diabetologica Latina

Pancreatic function and diabetesDiabetes Treatment and Management

Cited by 8